Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers World Congress 2016

Gyongyi Szabo's Biography

Gyongyi Szabo, Professor & Vice Chair for Research, Department of Medicine, University of Massachusetts Medical School

Gyongyi Szabo, MD, PhD, FAASDL, FACP, AGAF is the Worcester Foundation for Biomedical Sciences Endowed Chair, Associate Vice Provost for Interprofessional Education, Professor and Vice Chair of Medicine at the University of Massachusetts Medical School. Dr. Szabo is an internationally recognized leader in the field of liver immunology and inflammation. Her translational research and clinical investigations focus on alcoholic hepatitis, non-alcoholic fatty liver disease and viral hepatitis. She is the lead investigator on an NIH-supported multicenter clinical trial on alcoholic hepatitis. Her laboratory studies molecular mechanisms of inflammation and innate immunity to identify therapeutic targets and to explore translation of bench to bedside opportunities in liver diseases. Her recent research focuses on the role of Toll-like receptor and Nod-like receptor signaling pathways in alcoholic and non-alcoholic fatty liver diseases and the importance of micro-RNAs as biomarkers. In recognition of her contributions to medical research she was recently elected to the Hungarian Academy of Sciences. She serves on the Editorial Board of Hepatology, Nature Reviews Gartoenterology & Hepatology and on the Advisory Board of several agencies including the NIH ExRNA Consortium. She is President of the American Association for the Study of Liver Diseases in 2015.

Gyongyi Szabo Image

Exosomes as Circulating Biomarkers for Liver Disease

Tuesday, 22 March 2016 at 11:30

Add to Calendar ▼

Exosomes are heterogeneous membranous vesicles originating from multivesicular bodies in most cell types in the body. Recently, they emerged as potential biomarkers or disease, effective conveyors of intercellular communication, and vehicles for delivery of nucleic acid based therapy. Moreover, both the biomarker potential and pathophysiological roles for exosomes are beginning to be recognized in various liver diseases including alcoholic liver disease, hepatocellular carcinoma, non-alcoholic fatty liver disease, hepatitis B  and hepatitis C viral infections.

Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonCirculating Biomarkers World Congress 2016Circulating Biomarkers World Congress 2016 in Boston, USABoston,